2020
Anticoagulation-related nephropathy for the internist: a concise review.
Mezue K, Ram P, Egbuche O, Menezes R, Lerma E, Rangaswami J. Anticoagulation-related nephropathy for the internist: a concise review. Am J Cardiovasc Dis 2020, 10: 301-305. PMID: 33224577, PMCID: PMC7675155.Peer-Reviewed Original ResearchDirect-acting oral anticoagulantsAnticoagulation-related nephropathyDirect-acting oral anticoagulant useProgression to CKDWarfarin useOral anticoagulantsSignificant morbidityClinical entityTherapeutic strategiesSocioeconomic burdenNephropathyConcise reviewWarfarinAnticoagulationMorbidityPatientsCKDINRESRDReview
2017
Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
Mezue K, Obiagwu C, John J, Sharma A, Yang F, Shani J. Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban. Current Cardiology Reviews 2017, 13: 41-46. PMID: 27450450, PMCID: PMC5324317, DOI: 10.2174/1573403x12666160720092024.Peer-Reviewed Original ResearchConceptsFood and Drug AdministrationAtrial fibrillationReversal agentsClinical trialsNon-valvular atrial fibrillationSignificant mitral stenosisNovel oral anticoagulantsUS Food and Drug AdministrationOnset of actionPrimary safety outcomeClinical trial dataPrevention of strokeRate of strokeInhibitors of factor XaProsthetic heart valvesClinical bleedingApixaban useSystemic embolismOral anticoagulantsINR monitoringMitral stenosisDose variabilityNOACsApixabanCardiac arrhythmias